ESTIMATION OF PLASMA VOLUME IN PATIENTS PRESENTING WITH ACUTE DECOMPENSATED HEART FAILURE USING KAPLAN – HAKIM FORMULA AND CORRELATION OF PLASMA VOLUME SHIFT WITH OUTCOMES
DOI:
https://doi.org/10.22159/ajpcr.2023.v16i5.47887Keywords:
Kaplan–Hakim formula, Plasma volume shift, Acutede compensated heart failure, Worsening renal functionAbstract
Objective: Simple and non-invasive methods are required to estimate the plasma volume expansion to assess the congestion status in heart failure patients. To determine the effectiveness of Kaplan–Hakim formula in the quantification of the plasma volume expansion in acute decompensated heart failure (ADHF) and the correlation of the outcome factors with plasma volume shift (PVS).
Methods: This prospective study included 384 participants diagnosed with ADHF. Newly diagnosed cases and patients receiving treatment for the past 6 months were included. Kaplan–Hakim formula was used to estimate the plasma volume. Duration of hospital stay, subsequent hospitalization for heart failure (HHF), cardiovascular disease mortality, and all-cause mortality rate at the end of follow-up time was also noted.
Results: Among the study participants, 88 patients (22.92%) had PVS <5%, while the remaining 88.5% of the patients had PVS more than or equal to 5%. A strong association between guideline-recommended dose of ACEi/ARBs, beta-blockers, and normalcy of plasma volume status (p<0.001) was found. The mean duration of stay, number of repeated hospitalization, the incidence of worsening renal function, CV mortality rate, and all-cause mortality rate were significantly lower in participants with PVS ≥5% in comparison to those who had PVS < 5%. Kaplan–Hakim formula is a more practical and easy way to measure volume status in patients with ADHF.
Conclusion: The use of RAAS antagonists and beta-blockers in their optimal dosage is associated with favorable plasma volume status in chronic HF patients.
Downloads
References
Rocha BM, Falcão LM. Acute decompensated heart failure (ADHF): A comprehensive contemporary review on preventing early readmissions and postdischarge death. Int J Cardiol 2016;223:1035-44. doi: 10.1016/j.ijcard.2016.07.259
Desai AS, Stevenson LW. Rehospitalisation for heart failure: Predict or prevent? Circulation 2012;126:501-6. doi: 10.1161/ CIRCULATIONAHA.112.125435, PMID 22825412
Binanay C, Califf RM, Hasselblad V, O’Connor CM, Shah MR, Sopko G, et al. Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: The ESCAPE trial. JAMA 2005;294:1625-33. doi: 10.1001/jama.294.13.1625, PMID 16204662
Duarte K, Monnez JM, Albuisson E, Pitt B, Zannad F, Rossignol P. Prognostic value of estimated plasma volume in heart failure. JACC Heart Fail 2015;3:886-93. doi: 10.1016/j.jchf.2015.06.014, PMID 26541787
Heywood JT. The cardio-renal syndrome: Lessons from the ADHERE database and treatment options. Heart Fail Rev 2005;9:195-201. doi: 10.1007/s10741-005-6129-4
Ling HZ, Flint J, Damgaard M, Bonfils PK, Cheng AS, Aggarwal S, et al. Calculated plasma volume status and prognosis in chronic heart failure. Eur J Heart Fail 2015;17:35-43. doi: 10.1002/ejhf.193, PMID 25469484
Fudim M, Miller WL. Calculated estimates of plasma volume in patients with chronic heart failure - comparison with measured volumes. J Card Fail 2018;24:553-60. doi: 10.1016/j.cardfail.2018.07.462, PMID 30098381
Mosterd A, Hoes AW, Ten Berg JM, Van’t Hof AW, Tetsuro Y, et al. European heart journal: Acute cardiovascular. Eur Heart J Acute Cardiovasc Care 2014;1:8.
Martens P, Nijst P, Mullens W. Current approach to decongestive therapy in acute heart failure. Curr Heart Fail Rep 2015;12:367-78. doi: 10.1007/s11897-015-0273-5, PMID 26486631
Nijst P, Verbrugge FH, Grieten L, Dupont M, Steels P, Tang WH, et al. The pathophysiological role of interstitial sodium in heart failure. J Am Coll Cardiol 2015;65:378-88. doi: 10.1016/j.jacc.2014.11.025, PMID 25634838
Verbrugge FH, Dupont M, Steels P, Grieten L, Malbrain M, Tang WH, et al. Abdominal contributions to cardiorenal dysfunction in congestive heart failure. J Am Coll Cardiol 2013;62:485-95. doi: 10.1016/j. jacc.2013.04.070, PMID 23747781
Kociol RD, McNulty SE, Hernandez AF, Lee KL, Redfield MM, Tracy RP, et al. Markers of decongestion, dyspnea relief, and clinical outcomes among patients hospitalized with acute heart failure. Circ Heart Fail 2013;6:240-5. doi: 10.1161/CIRCHEARTFAILURE.112.969246, PMID 23250981
Fallick C, Sobotka PA, Dunlap ME. Sympathetically mediated changes in capacitance: Redistribution of the venous reservoir as a cause of decompensation. Circ Heart Fail 2011;4:669-75. doi: 10.1161/ CIRCHEARTFAILURE.111.961789, PMID 21934091
Abraham WT, Adamson PB, Bourge RC, Aaron MF, Costanzo MR, Stevenson LW, et al. Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: A randomised controlled trial. Lancet 2011;377:658-66. doi: 10.1016/S0140-6736(11)60101-3, PMID 21315441
Abraham WT, Compton S, Haas G, Foreman B, Canby RC, Fishel R, et al. Intrathoracic impedance vs daily weight monitoring for predicting worsening heart failure events: Results of the fluid accumulation status trial (FAST). Congest Heart Fail 2011;17:51-5. doi: 10.1111/j.1751- 7133.2011.00220.x, PMID 21449992
Kobayashi M, Girerd N, Duarte K, Preud’homme G, Pitt B, Rossignol P. Prognostic impact of plasma volume estimated from hemoglobin and hematocrit in heart failure with preserved ejection fraction. Clin Res Cardiol. 2020;109:1392-1401. doi: 10.1007/s00392-020-01639-4
Martens P, Nijst P, Dupont M, Mullens W. The optimal plasma volume status in heart failure in relation to clinical outcome. J Card Fail 2019;25:240-8. doi: 10.1016/j.cardfail.2018.11.019, PMID 30528705
Grodin JL, Philips S, Mullens W, Nijst P, Martens P, Fang JC, et al. Prognostic implications of plasma volume status estimates in heart failure with preserved ejection fraction: Insights from TOPCAT. Eur J Heart Fail 2019;21:634-42. doi: 10.1002/ejhf.1407, PMID 30714658
Mullens W, Abrahams Z, Francis GS, Sokos G, Taylor DO, Starling RC, et al. Importance of venous congestion for worsening of renal function in advanced decompensated heart failure. J Am Coll Cardiol 2009;53:589-96. doi: 10.1016/j.jacc.2008.05.068, PMID 19215833
McMurray JJV, Solomon SD, Inzucchi SE, Køber L, Kosiborod MN, Martinez FA, et al. Dapagliflozin in patients with heart failure and reduced ejection fraction. N Engl J Med 2019;381:1995-2008. doi: 10.1056/ NEJMoa1911303, PMID 31535829
Published
How to Cite
Issue
Section
Copyright (c) 2023 Dipak Rajan Das
This work is licensed under a Creative Commons Attribution 4.0 International License.
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.
